Search
for
Sort by
Research 241–270 of 1000+
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Pharmacological Treatment of Alopecia
- Energy-Based Devices in Male Skin Rejuvenation
- Anticoagulant-free preparation of autologous platelet-rich plasma (PRP) / fluid platelet-rich fibrin (f-PRF): a pre-clinical comparative performance study
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- Azelaic Acid in Dermatology: A Review of Its Mechanism of Action
- Design Synthesis and Characterisation of Silver Nanoparticals using Dracaena Trifasciata Extracts
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Aesthetics in Geriatrics Using Plasma and Its Fractions in India
- Hair and scalp dermatoscopy
- Physiologic skin changes in pregnancy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- What causes hidradenitis suppurativa ?—15 years after
- Next generation human skin constructs as advanced tools for drug development
- Diagnosis and Management of Alopecia in Children
- Skin manifestations of obesity: a comparative study
- Interventions for female pattern hair loss
- Sexuality in premature ovarian insufficiency
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Pregnancy and Skin
- Clinical Approach to the Patient With Alopecia
- The dermatological consequences of obesity
- Female Adolescent Hair Disorders
- What Ages Hair?
- Biology of Human Hair: Know Your Hair to Control It
- Skin health and integrity
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma